Cholecystokinin- and secretin-releasing peptides in the intestine-a new regulatory interendocrine mechanism in the gastrointestinal tract

Regulatory Peptides

Volumn 73, Issue 2, 1998, Pages 89-94

  Herzig, Karl Heinz ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

CCK; Feedback regulation; Intestine; Releasing peptides; Secretin

Indexed keywords

BOMBESIN; CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; DIAZEPAM BINDING INHIBITOR; PEPTIDE YY; RELEASING FACTOR; SECRETIN; SUBSTANCE P;

ARTICLE; FEEDBACK SYSTEM; GASTROINTESTINAL TRACT; HORMONAL REGULATION; HORMONE RELEASE; INTESTINE SECRETION; NONHUMAN; PANCREAS JUICE; PRIORITY JOURNAL; RAT;

AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; CHOLECYSTOKININ; DIAZEPAM BINDING INHIBITOR; DIGESTIVE SYSTEM; ENDOCRINE GLANDS; GROWTH SUBSTANCES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; RATS; SECRETIN; SWINE;

EID: 0032548992     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(97)01062-8     Document Type: Article

References (53)

1. Lyman R.L., Lepkovsky S. The effect of raw soybean meal and trypsin inhibitor diets on pancreatic enzyme secretion in the rat. J Nutr. 62:1957;264-284.
2. Green G.M., Lyman R.L. Feedback regulation of pancreatic enzyme secretion as a mechanism for trypsin inhibitor-induced hypersecretion in the rat. Proc Soc Exp Biol Med. 140:1972;6-12.
3. Ihse I., Lilja P., Lundquist I. Feedback regulation of pancreatic enzyme secretion by intestinal trypsin in man. Digestion. 15:1977;303-308.
4. Ihse I. Abolishment of oral trypsin inhibitor stimulation of the exocrine pancreas after duodenal resection. Scand J Gastroenterol. 11:1976;11-45.
5. Khayambashi H., Lyman R.L. Secretion of rat pancreas perfused with plasma from rats fed soybean trypsin inhibitor. Am J Physiol. 217:1969;646-651.
6. Louie D.S., May D., Miller P., Owyang C. Cholecystokinin mediates feedback regulation of pancreatic secretion in rats. Am J Physiol. 250:1986;G252-G259.
7. Fölsch U.R., Cantor P., Wilms H.M., Schafmayer A., Becker H.D., Creutzfeldt W. Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats. Gastroenterology. 92:1987;449-458.
8. Sun G., Lee K.Y., Chang T.-M., Chey W.Y. Effect of pancreatic juice diversion on secretin release in rats. Gastroenterology. 96:1989;1173-1179.
9. Fushiki T., Fukuoka S., Iwai K. Stimulation of rat pancreatic enzyme secretion by diet components. Agric Biol Chem. 48:1984;1867-1874.
10. Miyasaka K., Guan D., Liddle R.A., Green G.M. Feedback regulation by trypsin: evidence for intraluminal CCK-releasing peptide. Am J Physiol. 257:1989;G175-G181.
11. Lu L., Louie D., Owyang C. A cholecystokinin releasing peptide mediates feedback regulation of pancreatic secretion. Am J Physiol. 256:1989;G430-G435.
12. Herzig K.H., Louie D.S., Owyang C. Somatostatin inhibits CCK release by inhibiting secretion and action of CCK-releasing peptide. Am J Physiol. 266:1994;G1156-G1161.
13. Li P., Lee Y., Chang T.-M., Chey W.Y. Mechanism of acid-induced release of secretin in rats. Presence of a secretin-releasing peptide. J Clin Invest. 86:1990;1474-1479.
14. Iwai K., Fukuoka S.I., Fushiki T., Tsujikawa M., Hirose M., Tsunasawa S., Sakiyama F. Purification and sequencing of a trypsin-sensitive cholecystokinin-releasing peptide from rat pancreatic juice. J Biol Chem. 262:1987;8956-8959.
15. Herzig K.H., Schön I., Tatemoto K., Ohe Y., Li Y., Fölsch U.R., Owyang C. Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine. Proc Natl Acad Sci USA. 93:1996;7927-7932.
16. Spannagel A.W., Green G.M., Guan D., Liddle R.A., Faull K., Reeve Jr J.R. Purification and characterization of a luminal cholecystokinin-releasing factor from rat intestinal secretion. Proc Natl Acad Sci USA. 93:1996;4415-4420.
17. Uvnäs-Wallensten K. Luminal secretion of gut peptides. Clin Gastroenterol. 9:1980;545-553.
18. Playford R.J. Peptides and gastrointestinal integrity. Gut. 37:1995;595-597.
19. Sun G., Chang T., Xue W., Wey J.F.Y., Lee K.Y., Chey W.Y. Release of cholecystokinin and secretin by sodium oleate in dogs: molecular form and bioactivity. Am J Physiol. 262:1992;G35-G43.
20. Uvnäs-Wallensten K. The occurrence of gastrin in gastric juice, antral secretions and antral perfusates of anaesthetized cats. Gastroenterology. 73:1977;487-491.
21. Uvnäs-Wallensten K., Efendic S., Luft R., Johansson C. Phosphate buffer - a potent releaser of somatostatin in cats. Scand J Gastroenterol. 14:1980;797-800.
22. rd edition. New York: Raven Press, 1994:1-128.
23. Arimura A., Taminato T. Somatostatin in human pancreatic and gastric juice. Peptides. 2:1981;271-274.
24. Sarfati P., Green G.M., Braueau P., Morisset J. Presence of somatostatin-like immuno-reactivity in rat pancreatic juice: a physiological phenomenon. Can J Physiol Pharmacol. 64:1986;539-544.
25. Sarfati P., Morisset J. Regulation of pancreatic enzyme secretion in conscious rats by intraluminal somatostatin: mechanism of action. Endocrinology. 124:1989;2406-2414.
26. Guidotti A., Forchetti C.M., Corda M.G., Konkel D., Bennet C.D., Costa E. Isolation, characterization, and purification to homogeneity by an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc Natl Acad Sci USA. 80:1983;3531-3535.
27. Ferrero P., Guidotti A., Conti-Tronconi B., Costa E. A brain octadecaneuropeptide generated by tryptic digest of DBI (diazepam binding inhibitor) functions as a proconflict ligand of benzodiazepine recognition site. Neuropharmacology. 23:1984;1359-1362.
28. Ferrero P., Santi M., Conti-Tronconi B., Costa E., Guidotti A. Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): biological activity and presence in rat brain. Proc Natl Acad Sci USA. 83:1986;827-831.
29. Ferrero P., Costa E., Conti-Tronconi B., Guidotti A. A diazepam binding inhibitor (DBI)-like neuropeptide is detected in human brain. Brain Res. 399:1986;136-142.
30. 39-75, and characterization of its binding site in rat brain. Regul Pept. 50:1994;29-35.
31. Slobodyansky E., Guidotti A., Wambebe C., Berkovich A., Costa E. Isolation and characterization of a rat brain triakontatetraneuropeptide, a posttranslational product of diazepam binding inhibitor: specific action at the Ro 5-4864 recognition site. J Neurochem. 53:1989;1276-1284.
32. Costa E., Guidotti A. Diazepam binding inhibitor (DBI): a peptide with multiple biological actions. Life Sci. 49:1991;325-344.
33. Chen Z., Agerberth B., Gell K., Andersson M., Mutt V., Östenson C.-G., Effendic S., Barros-Söderling J., Persson B., Jörnvall H. Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release. Eur J Biochem. 174:1988;239-245.
34. Agerberth B., Borman A., Jörnvall H., Mutt V., Borman H.G. Isolation of three antibacterial peptides from pig intestine: gastric inhibitory polypeptide (7-42), diazepam-binding inhibitor (32-86) and a novel factor, peptide 3910. Eur J Biochem. 216:1993;623-629.
35. Knudsen J., Højrup P., Hansen H.O., Hansen H.F., Roepstorff P. Acyl-CoA-binding protein in the rat. Biochem J. 262:1989;513-519.
36. Papadopoulos V., Berkovich A., Krueger K.E., Costa E., Guidotti A. Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors. Endocrinology. 129:1991;1481-1488.
37. Garnier M., Boujard N., Oke B.O., Brown S., Riond J., Ferrara P., Shoyab M., Suares-Quian C.A., Papadopoulos V. Diazepam binding inhibitor is a paracrine/autocrine regulator of Leydig cell proliferation and steroidogenesis: action via peripheral-type benzodiazepine receptor and independent mechanisms. Endocrinology. 132:1993;444-458.
38. Östenson C.G., Ahren B., Johansson O., Karlsson S., Hilliges M., Efendic S. Diazepam binding inhibitor and the endocrine pancreas. Neuropharmacology. 30:1991;1391-1398.
39. Steyaert H., Tonon M.C., Tong Y., Smihrouet F., Testart J., Pelletier G., Vaudry H. Distribution and characterization of endogenous benzodiazepine receptor ligand (endo-zepine)-like peptides in the rat gastrointestinal tract. Endocrinology. 129:1991;2101-2109.
40. Herzig K.H., Wilgus C., Tatemoto K., Fölsch U.R. Effect of somatostatin, peptide YY and traurocholate on diazepam binding inhibitor stimulated cholecystokinin release from isolated intestinal mucosal cells. Regul Pept. 64:1996;66.
41. Guan D., Maouyo D., Tayler I.L., Gettys T.W., Greeley G.H. Jr. Peptide-YY, a new partner in the negative feedback control of pancreatic secretion. Endocrinology. 128:1991;911-916.
42. Koop I. Role of bile acids in the control of pancreatic secretion and CCK release. Eur J Clin Invest. 20(suppl. 1):1990;S51-S57.
43. Wiley J., Owyang C. Somatostatin inhibits cAMP-mediated cholinergic transmission in the myenteric plexus. Am J Physiol. 253:1987;G607-G612.
44. Whitcomb D.C., Hoffman G., Wood P.G., Kraykovic R.L., Spannagel A.W., Guan D., Liddle R.A., Reeve J.R. Jr., Green G.M. Luminal CCK releasing factor (LCRF) is a neuropeptide localized to nerves in the gastrointestinal tract and pancreas. Pancreas. 13:1996;461.
45. Fushiki T., Fukuoka S., Iwai K. Stimulatory effect of an endogenous peptide in rat pancreatic juice on pancreatic enzyme secretion in the presence of atropine: evidence for different mode of action of stimulation from exogenous trypsin inhibitors. Biochem Biophys Res Commun. 118:1984;532-537.
46. Fushiki T., Fukuoka H., Kajiura H., Iwai K. Atropine-nonsensitive feedback regulatory mechanism of rat pancreatic enzyme secretion in responses to food protein intake. J Nutr. 117:1987;948-954.
47. Cuber J.C., Bernard G., Fushiki T., Bernard C., Yamanishi R., Sugimoto E., Chayvialle J.A. Luminal CCK-releasing factors in the vascularly perfused rat duodenojejunum. Am J Physiol. 256:1989;G989-G996.
48. Bouras E.P., Misukonis M.A., Liddle R.A. Role of calcium in monitor peptide-stimulated cholecystokinin release from perifused intestinal cells. Am J Physiol. 262:1992;G791-G796.
49. Liddle R.A., Misukonis M.A., Pacy L., Balber A.E. Cholecystokinin cells purified by fluorescence-activated cell sorting respond to monitor peptide with an increase in intracellular calcium. Proc Natl Acad Sci USA. 89:1992;5147-5151.
50. Yamanishi R., Kotera J., Fushiki T., Soneda T., Saitoh T., Oomori T., Satoh T., Sugimoto E. A specific binding of the cholecystokinin-releasing peptide (monitor peptide) to isolated rat small-intestinal cells. Biochem J. 291:1993;57-63.
51. Tsuzuki S., Fushiki T., Kondo A., Murayama H., Sugimoto E. Effect of a high-protein diet on the gene expression of a trypsin-sensitive, cholecystokinin-releasing peptide (monitor peptide) in the pancreas. Eur J Biochem. 199:1991;245-252.
52. Tsuzuki S., Kondo A., Fushiki T., Sugimoto E. Monitor peptide gene expression is increased by exogenous CCK in the rat pancreas and in a rat pancreatic acinar cell line (AR4-2J). FEBS Lett. 307:1992;386-388.
53. Li P., Chang T.M., Chey W.Y. Neuronal regulation of the release and action of secretin-releasing peptide and secretin. Am J Physiol. 269:1995;G305-G312.